Botulinum toxin type a for the treatment of biceps/triceps co-contraction in obstetrical brachial plexus lesions

Botulinum toxin type a for the treatment of biceps/triceps co-contraction in obstetrical brachial... The local intramuscular application of botulinum toxin into the triceps, temporarily blocks activity and thus reduces the resistance to the weak but contracting biceps. Six children (2–4 years of age) presenting with severe biceps/triceps co-contractions after nerve regeneration (spontaneous regeneration in three cases, early microsurgical reconstruction in three cases) of an obstetrical brachial plexus lesion, were treated with local injections of 25 –50 mouse units (DYSPORT, R) botulinum toxin type A at two sites of the triceps muscle. Botulinum toxin injections were monitored by EMG recordings. Clinical testing (muscle power graded by the British Medical Research Council classification and measurement of the active range of motion, using the Neutral-0-Method) and EMG studies were performed prior to and after injections. Follow-up was at least 18 months. Mean active elbow flexion prior to application was about 50° (range: 20–60°) and muscle power was graded M1 (two cases) to M2 (four cases). Eighteen months after injection, mean elbow flexion was about 100° (range: 80–120°) and muscle power was graded as M2+ (elbow flexion without gravity in one case) to M4 (five cases). On EMG examination, a clear reduction of triceps contractions during biceps activity was observed. Temporary paralysis of the triceps after injection persisted for 16–44 weeks, with an average of 25.3 weeks. In order to achieve a stable elbow flexion at the M4 level, the Botox injection had to be repeated 2–3 times. The average time of treatment took 8–12 months. There was no recurrence of co-contraction in any of the patients after an 18 month follow-up. Moreover, no severe complications occurred. Local injections of botulinum toxin type A represents a new effective nonoperative tool for co-contracture treatment in obstetrical brachial plexus lesions in children. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Journal of Plastic Surgery Springer Journals

Botulinum toxin type a for the treatment of biceps/triceps co-contraction in obstetrical brachial plexus lesions

Loading next page...
 
/lp/springer_journal/botulinum-toxin-type-a-for-the-treatment-of-biceps-triceps-co-HNC8LMSoCx
Publisher
Springer-Verlag
Copyright
Copyright © 2001 by Springer-Verlag
Subject
Medicine & Public Health; Plastic Surgery
ISSN
0930-343X
eISSN
1435-0130
D.O.I.
10.1007/s002380000218
Publisher site
See Article on Publisher Site

Abstract

The local intramuscular application of botulinum toxin into the triceps, temporarily blocks activity and thus reduces the resistance to the weak but contracting biceps. Six children (2–4 years of age) presenting with severe biceps/triceps co-contractions after nerve regeneration (spontaneous regeneration in three cases, early microsurgical reconstruction in three cases) of an obstetrical brachial plexus lesion, were treated with local injections of 25 –50 mouse units (DYSPORT, R) botulinum toxin type A at two sites of the triceps muscle. Botulinum toxin injections were monitored by EMG recordings. Clinical testing (muscle power graded by the British Medical Research Council classification and measurement of the active range of motion, using the Neutral-0-Method) and EMG studies were performed prior to and after injections. Follow-up was at least 18 months. Mean active elbow flexion prior to application was about 50° (range: 20–60°) and muscle power was graded M1 (two cases) to M2 (four cases). Eighteen months after injection, mean elbow flexion was about 100° (range: 80–120°) and muscle power was graded as M2+ (elbow flexion without gravity in one case) to M4 (five cases). On EMG examination, a clear reduction of triceps contractions during biceps activity was observed. Temporary paralysis of the triceps after injection persisted for 16–44 weeks, with an average of 25.3 weeks. In order to achieve a stable elbow flexion at the M4 level, the Botox injection had to be repeated 2–3 times. The average time of treatment took 8–12 months. There was no recurrence of co-contraction in any of the patients after an 18 month follow-up. Moreover, no severe complications occurred. Local injections of botulinum toxin type A represents a new effective nonoperative tool for co-contracture treatment in obstetrical brachial plexus lesions in children.

Journal

European Journal of Plastic SurgerySpringer Journals

Published: Feb 6, 2001

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off